Abstract:Abstract Epidemiological studies have suggested luteolin (3′,4′,5,7-tetrahydroxyflavone) as a potential cancer preventive agent. Recently we found that luteolin selectively kills lung cancer but not immortalized human normal bronchial epithelial cells (HBECs). To elucidate the mechanism of luteolin's cancer cell killing activity, we investigated the cytotoxic cellular signaling pathway in lung cancer cells. The results show that luteolin potently induced both apoptosis and necrosis, which was associated with mitochondrion-dependent superoxide accumulation in lung cancer cells. The c-Jun N-terminal kinase (JNK) was substantially activated in luteolin treated cancer cells and luteolin-induced cytotoxicity was effectively blocked when JNK was inhibited. The reactive oxygen species scavengers BHA and NAC, which effectively block luteolin-induced superoxide accumulation, potently suppressed luteolin-induced JNK activation and cytotoxicity, suggesting that luteolin's lung cancer cell killing requires superoxide-mediated JNK activation. Furthermore, JNK activation was tightly associated with a superoxide-dependent rapid reduction of the JNK inactivating phosphatase MKP-1, which was mainly due to destabilizing MKP-1 protein. These results suggest that inhibiting MKP-1 is the main mechanism for luteolin-induced JNK activation. Thus, luteolin activates a novel cytotoxic pathway consisting of superoxide, MKP-1 and JNK in lung cancer cells. Interestingly, luteolin failed in inducing MKP-1 degradation and JNK activation and cell death in the HBECs, although superoxide induction by luteolin was comparable to that in lung cancer cells. Therefore, luteolin-induced cellular signaling in normal and lung cancer cells diverges at JNK activation. Taken together, our results suggest that activation of the speroxide/MKP1/JNK pathway underlies the main mechanism of luteolin's selective ctyotoxicity in lung cancer cells and manipulation of this pathway could be a useful approach for applying luteolin for lung cancer prevention and therapy. Citation Format: {Authors}. {Abstract title} [abstract]. In: Proceedings of the 101st Annual Meeting of the American Association for Cancer Research; 2010 Apr 17-21; Washington, DC. Philadelphia (PA): AACR; Cancer Res 2010;70(8 Suppl):Abstract nr 3797.

Exploring the Molecular Mechanisms of the Inhibition of Acrolein-Induced BEAS-2B Cytotoxicity by Luteolin Using Network Pharmacology and Cell Biology Technology

Toxicity Mechanism of Acrolein on DNA Damage and Apoptosis in BEAS-2B Cells: Insights from Cell Biology and Molecular Docking Analyses.

Mechanisms of Acrolein Induces Toxicity in Human Umbilical Vein Endothelial Cells: Oxidative Stress, DNA Damage Response, and Apoptosis.

A NETWORK PHARMACOLOGY-BASED TREATMENT ANALYSIS OF LUTEOLIN FOR REGULATING PYROPTOSIS IN ACUTE LUNG INJURY

Protective Effects and Mechanisms of Luteolin against Acute Respiratory Distress Syndrome: Network Pharmacology and In vivo and In vitro Studies

Integrating Network Pharmacology and Mechanism Study

Abstract A63: Superoxide-dependent MKP-1 Degradation and JNK Activation Contribute to Luteolin-Induced Cytotoxicity in Lung Cancer Cells

Luteolin Inhibits Nrf2 Leading to Negative Regulation of the Nrf2/Are Pathway and Sensitization of Human Lung Carcinoma A549 Cells to Therapeutic Drugs

Protective Effects of Asiatic Acid Against D-galactosamine/lipopolysaccharide-induced Hepatotoxicity in Hepatocytes and Kupffer Cells Co-Cultured System Via Redox-Regulated Leukotriene C4 Synthase Expression Pathway

A Superoxide-Mediated Mitogen-Activated Protein Kinase Phosphatase-1 Degradation and C-Jun NH2-Terminal Kinase Activation Pathway for Luteolin-Induced Lung Cancer Cytotoxicity

Abstract 3797: Luteolin Induces Cytotoxicity in Lung Cancer Cells Depending on Superoxide-Mediated MKP-1 Degradation and JNK Activation

Arecoline-Induced Hepatotoxicity in Rats: Screening of Abnormal Metabolic Markers and Potential Mechanisms

Protective effect of luteolin on cigarette smoke extract-induced cellular toxicity and apoptosis in normal human bronchial epithelial cells via the Nrf2 pathway.

Mechanism of luteolin against non-small-cell lung cancer: a study based on network pharmacology, molecular docking, molecular dynamics simulation, and in vitro experiments

Acrolein Evokes Inflammation and Autophagy-Dependent Apoptosis Through Oxidative Stress in Vascular Endothelial Cells and Its Protection by 6-C-(e-2-fluorostyryl)naringenin

Exploring the mechanism of astaxanthin against lipopolysaccharide-induced acute lung injury by network pharmacology and experimental validation

Molecular mechanism of luteolin against inflammation based on integration of network pharmacology, transcriptomics and proteomics

Combined Cytotoxicity of Co-Exposure to Aldehyde Mixtures on Human Bronchial Epithelial BEAS-2B Cells

A Critical Role Of Luteolin-Induced Reactive Oxygen Species In Blockage Of Tumor Necrosis Factor-Activated Nuclear Factor-Kappa B Pathway And Sensitization Of Apoptosis In Lung Cancer Cells

Antagonistic Efficacy of Luteolin against Lead Acetate Exposure-Associated with Hepatotoxicity is Mediated via Antioxidant, Anti-Inflammatory, and Anti-Apoptotic Activities

Inhibition of lincRNA-Cox2 alleviates apoptosis and inflammatory injury of lipopolysaccharide-stimulated human bronchial epithelial cells via the Nrf2/HO-1 axis